Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-370.79	-91.07	-19.34
Graham Fair Price	-43.79	23.49	41.79
PEG	29.80	< 0.005	-0.01
Price/Book	35.03	-0.15	-0.23
Price/Cash Flow	-155.35	-2.04	-0.80
Prices/Earnings	-133.10	-0.65	-0.28
Price/Sales	-73.59	0.31	1.19
Price/FCF	-155.35	-2.04	-0.80
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	94.59	-0.05	-0.96
Operating Margin	87.84	-0.13	-1.09
ROA	69.85	-0.02	-0.05
ROE	0.20	0.06	-72.13
ROIC	-0.06	-0.02	67.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	0.07	-47.67
Dividends QOQ	0.07	0.11	62.11
EBIT QOQ	0.21	0.68	220.71
EPS QOQ	0.21	0.70	232.03
FCF QOQ	0.06	0.73	1085.69
Revenue QOQ	-0.50	1.61	220.46
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	5.60	3.86	-31.20
Days Sales Outstanding (DSO)	115.50	51.47	-55.44
Inventory Turnover	16.06	23.34	45.34
Debt/Capitalization	1.38	1.44	4.17
Quick Ratio	0.22	0.25	13.02
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-19.52	-20.78	-6.47
Cash	8.64	9.68	11.94
Capex	-1.55	-0.32	79.54
Free Cash Flow	-5.53	-1.50	72.91
Revenue	3.72	9.73	161.88
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.26	0.26	2.65
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-18.06	-86.54	-379.26
Naive Interpretation	Member

06 - Financial Health · Bad

Rating